tiprankstipranks
Trending News
More News >
Xvivo Perfusion AB (SE:XVIVO)
OTHER OTC:XVIVO
Sweden Market

Xvivo Perfusion AB (XVIVO) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
2Neutral
7Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Xvivo Perfusion AB’s (XVIVO) Moving Averages Convergence Divergence (MACD) indicator is 2.77, suggesting Xvivo Perfusion AB is a Sell.
Xvivo Perfusion AB’s (XVIVO) 20-Day exponential moving average is 183.58, while Xvivo Perfusion AB’s (XVIVO) share price is kr176, making it a Buy.
Xvivo Perfusion AB’s (XVIVO) 50-Day exponential moving average is 181.11, while Xvivo Perfusion AB’s (XVIVO) share price is kr176, making it a Buy.

Xvivo Perfusion AB (XVIVO) Pivot Points

Jan 12, 2026, 06:20 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
172.33
176.27
180.83
184.77
189.33
193.27
197.83
Fibonacci
176.27
179.51
181.52
184.77
188.01
190.02
193.27
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xvivo Perfusion AB (XVIVO) Moving Averages

Jan 12, 2026, 06:20 PM
Period
Simple
Exponential
MA5
185.10Buy
187.90Buy
MA10
185.82Buy
185.87Buy
MA20
183.53Buy
183.58Buy
MA50
179.47Buy
181.11Buy
MA100
176.50Buy
192.91Buy
MA200
226.97Sell
247.90Sell
Xvivo Perfusion AB’s (XVIVO) 10-Day exponential moving average is 185.87, while Xvivo Perfusion AB’s (XVIVO) share price is kr176, making it a Buy.
Xvivo Perfusion AB’s (XVIVO) 100-Day exponential moving average is 192.91, while Xvivo Perfusion AB’s (XVIVO) share price is kr176, making it a Buy.
Xvivo Perfusion AB’s (XVIVO) stock price is kr176 and Xvivo Perfusion AB’s (XVIVO) 50-day simple moving average is 179.47, creating a Buy signal.
Xvivo Perfusion AB’s (XVIVO) stock price is kr176 and Xvivo Perfusion AB’s (XVIVO) 100-day simple moving average is 176.50, creating a Buy signal.
Xvivo Perfusion AB’s (XVIVO) stock price is kr176 and Xvivo Perfusion AB’s (XVIVO) 200-day simple moving average is 226.97, creating a Sell signal.

Xvivo Perfusion AB (XVIVO) Technical Indicators

Jan 12, 2026, 06:20 PM
Name
Value
Implied Action
RSI (14)
59.47
Neutral
STOCH (9,6)
84.11
Sell
STOCHRSI (14)
85.26
Sell
MACD (12,26)
2.77
Sell
ADX (14)
13.79
Buy
Williams %R
-9.60
Sell
CCI (14)
197.77
Sell
ATR (14)
8.06
-
Ultimate Oscillator
61.02
Neutral
ROC
8.88
Buy
Xvivo Perfusion AB’s (XVIVO) Relative Strength Index (RSI) is 59.47, creating a Neutral signal.
Xvivo Perfusion AB’s (XVIVO) Trend Strength Indicator (ADX) is 13.79, creating a Buy signal.
Xvivo Perfusion AB’s (XVIVO) Commodity Channel Index (CCI) is 197.77, creating a Sell signal.
Xvivo Perfusion AB’s (XVIVO) Price Rate of Change (ROC) is 8.88, creating a Buy signal.

FAQ

Is XVIVO a Buy, Hold, or Sell?
Based on XVIVO’s technical indicators, XVIVO is a Buy.
    What is XVIVO’s RSI (14)?
    XVIVO’s RSI (14) is 59.47, which suggests XVIVO is a Neutral.
      What is XVIVO’s MACD?
      XVIVO’s MACD is 2.77, which suggests XVIVO is a Sell.
        What is XVIVO’s 5-day moving average?
        XVIVO’s 5-day moving average is 185.10, which suggests XVIVO is a Buy.
          What is XVIVO’s 20-day moving average?
          XVIVO 20-day moving average is 183.53, which suggests XVIVO is a Buy.
            What is XVIVO’s 50-day moving average?
            XVIVO’s 50-day moving average is 179.47, which suggests XVIVO is a Buy.
              What is XVIVO’s 200-day moving average?
              XVIVO’s 200-day moving average is 226.97, which suggests XVIVO is a Sell.
                What is XVIVO’s Williams % R (14)?
                XVIVO’s Williams % R (14) is -9.60, which suggests XVIVO is a Sell.
                  What is XVIVO’s CCI (14)?
                  XVIVO’s CCI (14) is 197.77, which suggests XVIVO is a Sell.
                    What is the share price of Xvivo Perfusion AB?